skin cancer
Merck Terminates Phase III Trials of Keytruda in Certain Cancers
The trials failed to show benefits compared to placebo during prespecified interim analyses.
Akoya Biosciences, NeraCare Partner to Develop Melanoma Tests
The companies will develop tests for patient stratification and therapy selection for early melanoma using the PhenoImager HT platform and Immunoprint assay.
BostonGene, Duke University School of Medicine Strike Cancer Research Alliance
The partners plan to collaborate on research projects across a range of cancers with the goal of improving patient responses to treatment.
Bicara Therapeutics Raises $165M in Oversubscribed Series C Financing
The company will use the funds to develop its EGFR/TGF-β inhibitor BCA101 in HPV-negative cancers including head and neck, lung, and skin cancers.
The company discussed what it believes are compelling new results on the impact of its testing on patient outcomes during a call discussing its Q1 earnings.